Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.

Orlowski A, Gale CP, Ashton R, Petrungaro B, Slater R, Nadarajah R, Cowan JC, Buck J, Smith W, Wu J

Open source

DOI
10.1136/heartjnl-2020-317006
Published
2021 Jan
Container
Heart (British Cardiac Society)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/heartjnl-2020-317006,
  title = {Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.},
  author = {Orlowski A and Gale CP and Ashton R and Petrungaro B and Slater R and Nadarajah R and Cowan JC and Buck J and Smith W and Wu J},
  year = {2021},
  journal = {Heart (British Cardiac Society)},
  doi = {10.1136/heartjnl-2020-317006},
  url = {https://doi.org/10.1136/heartjnl-2020-317006}
}

RIS

TY  - JOUR
TI  - Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.
AU  - Orlowski A
AU  - Gale CP
AU  - Ashton R
AU  - Petrungaro B
AU  - Slater R
AU  - Nadarajah R
AU  - Cowan JC
AU  - Buck J
AU  - Smith W
AU  - Wu J
PY  - 2021
JO  - Heart (British Cardiac Society)
DO  - 10.1136/heartjnl-2020-317006
UR  - https://doi.org/10.1136/heartjnl-2020-317006
ER  - 

APA

A, O., CP, G., R, A., B, P., R, S., R, N., JC, C., J, B., W, S., & J, W. (2021). Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.. Heart (British Cardiac Society). https://doi.org/10.1136/heartjnl-2020-317006

Source records